Articles Tagged With: hormone
-
Research Examines Options for Those With Early-stage Breast Cancer
Results of a large-scale study indicated that 70% of women with a common type of breast cancer do not experience a benefit from chemotherapy. Data suggest that for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, axillary lymph node-negative breast cancer, post-surgery combination chemotherapy and hormone therapy treatment provides no additional benefit over hormone therapy on its own.
-
What Do the Urinary Microbiota and Incontinence Have to Do With Each Other?
Increased diversity of the microbiota in women is associated with urgency urinary incontinence symptoms but not with stress urinary incontinence symptoms.
-
Task Force Recommends Against Hormone Therapy for Chronic Conditions
The U.S. Preventive Services Task Force has issued a final recommendation statement and evidence summary upholding its earlier recommendation against use of hormone therapy for the primary prevention of chronic conditions in postmenopausal women.
-
Should Perimenopausal Women Consider Estrogen Therapy?
A population-based study found that premenopausal women with low ovarian reserve, as determined by low levels of anti-Müllerian hormone, have unfavorable cardiovascular disease profiles.
-
Data Suggest Hormonal Therapy Doesn’t Increase VTE Risk in Women on Anticoagulant Therapy
Women on anticoagulant therapy can take estrogen-containing contraception or hormone therapy without an increased risk of blood clots or uterine bleeding, findings from a recent study suggest.
-
Management of your patients’ menopause — Is your care on the right track?
By 2020, more than 50 million U.S. women will be older than 51, the mean age when menopause occurs. Despite the availability of effective hormonal and nonhormonal treatments for menopausal symptoms, few women with menopausal symptoms are evaluated or treated, reports a new scientific perspective.
-
Counsel women on how to cope with menopause’s vasomotor symptoms
New research indicates that frequent vasomotor symptoms associated with menopause could last more than seven years for many women.